Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy|Continue
JAMA Neurology
Sign In
Individual Sign In
Sign inCreate an Account
Access through your institution
Sign In
New Online
Original Investigation
May28, 2024
Martina B.Goeldlin,MD, PhD1; ArsanyHakim,MD2; MattiaBranca,PhD3; et al StefanieAbend,BSc1; MarkusKneihsl,MD1,4,5,6; WaldoValenzuela Pinilla,PhD7; SabineFenzl,MD2; BeataRezny-Kasprzak,MD2; RomanRohner,MD2; DanielStrbian,MD, PhD8; MaurizioPaciaroni,MD9; GoetzThomalla,MD10; PatrikMichel,MD11; KrassenNedeltchev,MD1,12; ThomasGattringer,MD, PhD5,6; Else CharlotteSandset,MD, PhD13; LeoBonati,MD4,14; DianaAguiar de Sousa,MD, PhD15,16; P. N.Sylaja,MD17; GeorgeNtaios,MD18; MasatoshiKoga,MD, PhD19; ZuzanaGdovinova,MD, PhD20,21; RobinLemmens,MD, PhD22,23; Natan M.Bornstein,MD24; PeterKelly,MD, PhD25; MiraKatan,MD4; ThomasHorvath,MD1; JesseDawson,MD26; UrsFischer,MD, MSc1,4; for the ELAN Investigators
Author Affiliations Article Information
-
1Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
-
2University Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
-
3Clinical Trials Unit, University of Bern, Bern, Switzerland
-
4Department of Neurology, University of Basel and University Hospital Basel, Basel, Switzerland
-
5Department of Neurology, Medical University of Graz, Graz, Austria
-
6Division of Neuroradiology, Vascular and Interventional Radiology, Department of Radiology, Medical University of Graz, Graz, Austria
-
7Support Center for Advanced Neuroimaging, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland
-
8Department of Neurology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
-
9Internal, Vascular, and Emergency Medicine, Stroke Unit, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy
-
10Department of Neurology, University Medical Center Hamburg–Eppendorf, Hamburg, Germany
-
11Department of Neurology, University Hospital Lausanne, University of Lausanne, Lausanne, Switzerland
-
12Department of Neurology, Cantonal Hospital Aarau, Aarau, Switzerland
-
13Department of Neurology, Oslo University Hospital, Oslo, Norway
-
14Research Department, Reha Rheinfelden, Rheinfelden, Switzerland
-
15Stroke Center, Lisbon Central University Hospital, Lisbon, Portugal
-
16Faculty of Medicine, Institute of Anatomy, University of Lisbon, Lisbon, Portugal
-
17Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
-
18Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
-
19Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan
-
20Department of Neurology, Pavol Jozef Šafárik University, Košice, Slovakia
-
21Faculty of Medicine, Louis Pasteur University Hospital, Košice, Slovakia
-
22Department of Neurosciences, Experimental Neurology, KU Leuven, Leuven, Belgium
-
23Department of Neurology, University Hospitals Leuven, Leuven, Belgium
-
24Department of Neurology, Shaare-Zedek Medical Center, Jerusalem, Israel
-
25Stroke Clinical Trials Network Ireland, School of Medicine, University College Dublin and Department of Neurology, Mater University Hospital, Dublin, Ireland
-
26School of Cardiovascular and Metabolic Health, Queen Elizabeth University Hospital, University of Glasgow, Glasgow, United Kingdom
JAMA Neurol. Published online May 28, 2024. doi:10.1001/jamaneurol.2024.1450
Audio (18:13)
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
1x
0:00 / 0:00
Subscribe to Podcast
Full Text
Question Does infarct size modify the safety and efficacy of early vs late initiation of direct oral anticoagulation (DOAC) after ischemic stroke in people with atrial fibrillation?
Findings In this post hoc analysis of 1962 participants from the Early Versus Later Anticoagulation for Stroke With Atrial Fibrillation (ELAN) randomized clinical trial, the odds of the primary outcome (recurrent ischemic stroke, symptomatic intracranial hemorrhage, extracranial bleeding, systemic embolism, or vascular death within 30 days) were similar for early vs late DOAC initiation among participants with minor, moderate, and major stroke.
Meaning Early DOAC treatment was not associated with a higher rate of bleeding complications, especially symptomatic intracranial hemorrhage, or any adverse events regardless of infarct size, including major stroke.
Abstract
Importance Whether infarct size modifies the treatment effect of early vs late direct oral anticoagulant (DOAC) initiation in people with ischemic stroke and atrial fibrillation is unknown.
Objective To assess whether infarct size modifies the safety and efficacy of early vs late DOAC initiation.
Design, Setting, and Participants Post hoc analysis of participants from the multinational (>100 sites in 15 countries) randomized clinical Early Versus Later Anticoagulation for Stroke With Atrial Fibrillation (ELAN) trial who had (1) acute ischemic stroke, (2) atrial fibrillation, and (3) brain imaging available before randomization. The ELAN trial was conducted between October 2017 and December 2022. Data were analyzed from October to December 2023 for this post hoc analysis.
Intervention Early vs late DOAC initiation after ischemic stroke. Early DOAC initiation was within 48 hours for minor or moderate stroke or on days 6 to 7 for major stroke; late DOAC initiation was on days 3 to 4 for minor stroke, days 6 to 7 for moderate stroke, and days 12 to 14 for major stroke.
Main Outcomes and Measures The primary outcome was a composite of recurrent ischemic stroke, symptomatic intracranial hemorrhage, extracranial bleeding, systemic embolism, or vascular death within 30 days. The outcome was assessed according to infarct size (minor, moderate, or major) using odds ratios and risk differences between treatment arms. Interrater reliability for infarct size between the core laboratory and local raters was assessed, and whether this modified the estimated treatment effects was also examined.
Results A total of 1962 of the original 2013 participants (909 [46.3%] female; median [IQR] age, 77 [70-84] years) were included. The primary outcome occurred in 10 of 371 participants (2.7%) with early DOAC initiation vs 11 of 364 (3.0%) with late DOAC initiation among those with minor stroke (odds ratio [OR], 0.89; 95% CI, 0.38-2.10); in 11 of 388 (2.8%) with early DOAC initiation vs 14 of 392 (3.6%) with late DOAC initiation among those with moderate stroke (OR, 0.80; 95% CI, 0.35-1.74); and in 8 of 219 (3.7%) with early DOAC initiation vs 16 of 228 (7.0%) with late DOAC initiation among those with major stroke (OR, 0.52; 95% CI, 0.21-1.18). The 95% CI for the estimated risk difference of the primary outcome in early anticoagulation was −2.78% to 2.12% for minor stroke, −3.23% to 1.76% for moderate stroke, and −7.49% to 0.81% for major stroke. There was no significant treatment interaction for the primary outcome. For infarct size, interrater reliability was moderate (κ = 0.675; 95% CI, 0.647-0.702) for local vs core laboratory raters and strong (κ = 0.875; 95% CI, 0.855-0.894) between core laboratory raters.
Conclusions and Relevance The treatment effect of early DOAC initiation did not differ in people with minor, moderate, or major stroke assessed by brain imaging. Early treatment was not associated with a higher rate of adverse events, especially symptomatic intracranial hemorrhage, for any infarct size, including major stroke.
Trial Registration ClinicalTrials.gov Identifier: NCT03148457
Full Text
Add or change institution
Comment
Read More About
Anticoagulation Neurology Cerebrovascular Disease Stroke Cerebrovascular Infarction Clinical Pharmacy and Pharmacology Atrial Fibrillation Cardiology Rhythm Disorders Bleeding and Transfusion Cerebrovascular Hemorrhage
Citation
Goeldlin MB, Hakim A, Branca M, et al. Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial. JAMA Neurol. Published online May 28, 2024. doi:10.1001/jamaneurol.2024.1450
Manage citations:
Ris (Zotero) EndNote BibTex Medlars ProCite RefWorks Reference Manager Mendeley
© 2024
Comment
Add or change institution
Artificial Intelligence ResourceCenter
Others Also Liked
Select Your Interests
Customize your JAMA Network experience by selecting one or more topics from the list below.
- Academic Medicine
- Acid Base, Electrolytes, Fluids
- Allergy and Clinical Immunology
- American Indian or Alaska Natives
- Anesthesiology
- Anticoagulation
- Art and Images in Psychiatry
- Artificial Intelligence
- Assisted Reproduction
- Bleeding and Transfusion
- Cardiology
- Caring for the Critically Ill Patient
- Challenges in Clinical Electrocardiography
- Climate and Health
- Climate Change
- Clinical Challenge
- Clinical Decision Support
- Clinical Implications of Basic Neuroscience
- Clinical Pharmacy and Pharmacology
- Complementary and Alternative Medicine
- Consensus Statements
- Coronavirus (COVID-19)
- Critical Care Medicine
- Cultural Competency
- Dental Medicine
- Dermatology
- Diabetes and Endocrinology
- Diagnostic Test Interpretation
- Drug Development
- Electronic Health Records
- Emergency Medicine
- End of Life, Hospice, Palliative Care
- Environmental Health
- Equity, Diversity, and Inclusion
- Ethics
- Facial Plastic Surgery
- Gastroenterology and Hepatology
- Genetics and Genomics
- Genomics and Precision Health
- Geriatrics
- Global Health
- Guide to Statistics and Methods
- Guidelines
- Hair Disorders
- Health Care Delivery Models
- Health Care Economics, Insurance, Payment
- Health Care Quality
- Health Care Reform
- Health Care Safety
- Health Care Workforce
- Health Disparities
- Health Inequities
- Health Policy
- Health Systems Science
- Hematology
- History of Medicine
- Humanities
- Hypertension
- Images in Neurology
- Implementation Science
- Infectious Diseases
- Innovations in Health Care Delivery
- JAMA Infographic
- Law and Medicine
- Leading Change
- Less is More
- LGBTQIA Medicine
- Lifestyle Behaviors
- Medical Coding
- Medical Devices and Equipment
- Medical Education
- Medical Education and Training
- Medical Journals and Publishing
- Melanoma
- Mobile Health and Telemedicine
- Narrative Medicine
- Nephrology
- Neurology
- Neuroscience and Psychiatry
- Notable Notes
- Nursing
- Nutrition
- Nutrition, Obesity, Exercise
- Obesity
- Obstetrics and Gynecology
- Occupational Health
- Oncology
- Ophthalmology
- Orthopedics
- Otolaryngology
- Pain Medicine
- Palliative Care
- Pathology and Laboratory Medicine
- Patient Care
- Patient Information
- Pediatrics
- Performance Improvement
- Performance Measures
- Perioperative Care and Consultation
- Pharmacoeconomics
- Pharmacoepidemiology
- Pharmacogenetics
- Pharmacy and Clinical Pharmacology
- Physical Medicine and Rehabilitation
- Physical Therapy
- Physician Leadership
- Poetry
- Population Health
- Primary Care
- Professional Well-being
- Professionalism
- Psychiatry and Behavioral Health
- Public Health
- Pulmonary Medicine
- Radiology
- Regulatory Agencies
- Reproductive Health
- Research, Methods, Statistics
- Resuscitation
- Rheumatology
- Risk Management
- Scientific Discovery and the Future of Medicine
- Shared Decision Making and Communication
- Sleep Medicine
- Sports Medicine
- Stem Cell Transplantation
- Substance Use and Addiction Medicine
- Surgery
- Surgical Innovation
- Surgical Pearls
- Teachable Moment
- Technology and Finance
- The Art of JAMA
- The Arts and Medicine
- The Rational Clinical Examination
- Tobacco and e-Cigarettes
- Toxicology
- Translational Medicine
- Trauma and Injury
- Treatment Adherence
- Ultrasonography
- Urology
- Users' Guide to the Medical Literature
- Vaccination
- Venous Thromboembolism
- Veterans Health
- Violence
- Women's Health
- Workflow and Process
- Wound Care, Infection, Healing
Save Preferences
Privacy Policy | Terms of Use
X
.
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)—
Sign in or create a free account
Rent this article from DeepDyve
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)—
Sign in or create a free account
Rent this article from DeepDyve
Sign in to access free PDF
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Save your search
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Customize your interests
Free access to newly published articles
To register for email alerts, access free PDF, and more
Create a personal account or sign in to:
- Register for email alerts with links to free full-text articles
- Access PDFs of free articles
- Manage your interests
- Save searches and receive search alerts
Privacy Policy
Make a comment
Free access to newly published articles
To register for email alerts, access free PDF, and more
Create a personal account or sign in to:
- Register for email alerts with links to free full-text articles
- Access PDFs of free articles
- Manage your interests
- Save searches and receive search alerts
Privacy Policy